Seelos Therapeutics's total assets for Q3 2023 were $6.22M, a decrease of -47.70% from the previous quarter. SEEL total liabilities were $36.63M for the fiscal quarter, a -37.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.